Patient-Reported Outcomes (PROs) during a Study of Feasibility of Continuous Glucose Monitor (CGM) Use in Publicly Insured Youth with Type 2 Diabetes (T2D)

被引:0
|
作者
Tanenbaum, Molly L.
Hanes, Sarah
Hood, Korey K.
Maahs, David M.
Shah, Sejal
机构
关键词
D O I
10.2337/db23-1114-P
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1114-P
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Feasibility of Continuous Glucose Monitor Use in Publicly Insured Youth with Type 2 Diabetes
    Shah, Sejal
    Arrizon-Ruiz, Nora
    Loyola, Alondra
    Sagan, Piper
    Conrad, Barry P.
    Leverenz, Jeannine
    Bishop, Franziska K.
    Maahs, David M.
    DIABETES, 2023, 72
  • [2] Patient-Reported Outcomes (PROs) to Treatment in Type 2 Diabetes (T2D) from the International Diabetes Management Practices Study (IDMPS)
    Aschner, Pablo
    Gagliardino, Juan J.
    Ilkova, Hasan M.
    Ramachandran, Ambady
    Mbanya, Jean Claude
    Shestakova, Marina V.
    Pilorget, Valerie
    Melas-Melt, Lydie
    Chantelot, Jean-Marc
    Chan, Juliana C.
    DIABETES, 2022, 71
  • [3] Changes in insurance policy help to increase continuous glucose monitoring (CGM) use in youth with type 2 diabetes (T2D)
    Zeier, T.
    Smith, J.
    Lubarsky, T.
    Barber, R.
    Chao, L.
    Chang, N.
    HORMONE RESEARCH IN PAEDIATRICS, 2024, 97 : 288 - 289
  • [4] Improved BMI Category Is Associated with Better Patient-Reported Outcomes (PROs) in Adults with T2D Treated with Tirzepatide
    Lee, Clare
    Boye, Kristina
    Thieu, Vivian
    Allen, Sheryl
    Dong, Wenxiu
    Sapin, Helene
    DIABETES, 2023, 72
  • [5] Expanding the use of patient-reported outcomes (PROs): Screening youth with type 1 diabetes from underrepresented populations
    Addala, Ananta
    Wong, Jessie J.
    Penaranda, Ricardo Medina
    Hanes, Sarah J.
    Abujaradeh, Hiba
    Adams, Rebecca N.
    Barley, Regan C.
    Iturralde, Esti
    Lanning, Monica S.
    Tanenbaum, Molly L.
    Naranjo, Diana
    Hood, Korey K.
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2023, 37 (07)
  • [6] Real-Time Continuous Glucose Monitor (RTCGM) Use Associated with Decreased Diabetes Medical Costs for Patients with Type 2 Diabetes (T2D)
    Norman, Gregory J.
    Paudel, Misti L.
    Bancroft, Tim
    Lynch, Peter M.
    DIABETES, 2021, 70
  • [7] A1C Reductions and Improved Patient-Reported Outcomes following CGM Initiation in Insulin-Managed T2D
    Noar, Adam
    Welsh, John
    Price, David A.
    DIABETES, 2020, 69
  • [8] Continuous Glucose Monitoring in Youth with Type 2 Diabetes: A Pilot and Feasibility Study
    Chesser, Hannah
    Srinivasan, Shylaja
    Wong, Jenise C.
    DIABETES, 2021, 70
  • [9] Demographic and Medical Correlates of Caregiver Reported Benefits and Burdens of Continuous Glucose Monitor (CGM) Use among Racially Minoritized Youth with Type 1 Diabetes (T1D)
    Vemulakonda, Madhu
    Straton, Emma
    Wang, Christine H.
    Barber, John
    Gallant, Letitia
    Kang, Leyi
    Majidi, Shideh
    Perkins, Amanda G.
    Streisand, Randi
    DIABETES, 2024, 73
  • [10] Correlates of Blood Glucose Monitoring (BGM) in Youth with Type 2 Diabetes (T2D): The TODAY Study Experience
    Mcguigan, Paul
    Larkin, Mary E.
    Grover, Nisha B.
    Laffel, Lori M.
    Abramson, Natalie W.
    Lauer, Abigail
    Barajas, Rose Ann
    Celona-Jacobs, Nicole
    Chang, Nancy
    Porter, Kristin
    DIABETES, 2014, 63 : A313 - A313